Agilent Technologies Inc (N:A)

Business Focus: Advanced Medical Equipment & Technology

Apr 16, 2024 08:00 am ET
Agilent Receives Scientists' Choice Awards for Sustainability
Agilent Technologies Inc. (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year. These awards recognize Agilent as a leader in the area of sustainability.
Apr 15, 2024 08:00 am ET
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
Agilent Technologies Inc. (NYSE: A) today announced that its
Apr 04, 2024 08:00 am ET
Agilent Brings Great Science to Life at Analytica 2024
Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany.
Apr 03, 2024 08:00 am ET
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences and diagnostics, announced today its participation in the
Apr 02, 2024 08:00 am ET
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, and the
Apr 01, 2024 08:00 am ET
Agilent Launches New Advanced Dilution System to Increase Lab Efficiency
Agilent Technologies Inc. (NYSE: A) today announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall effic
Mar 14, 2024 08:00 am ET
Agilent Presents 2024 Darlene Solomon Award to University of Cambridge Researcher Joycelyn Tan
Agilent Technologies Inc. (NYSE: A) announced today that Joycelyn Tan, a Ph.D. student at the
Feb 29, 2024 08:00 am ET
Agilent Presents Solutions Innovation Research Awards to Drexel University and Prairie View A&M University Researchers
Agilent Technologies Inc. (NYSE: A) today announced the selection of Distinguished Professors Michel Barsoum and Yury Gogotsi at
Feb 27, 2024 04:05 pm ET
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.66 billion for the first quarter ended Jan. 31, 2024, a decline of 5.6% reported and 6.4% core(1) compared to the first quarter of 2023.
Feb 21, 2024 04:20 pm ET
Agilent Announces Cash Dividend of 23.6 Cents per Share
Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on April 24, 2024, to all shareholders of record as of the close of business on April 2, 2024.
Feb 21, 2024 04:12 pm ET
Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect
Agilent Technologies Inc. (NYSE: A) today announced that Padraig McDonnell, president of the Agilent CrossLab Group (ACG), has been named CEO-elect and chief operating officer (COO) of the company, succeeding current President and CEO Mike McMullen who will retire. McDonnell will become Agilent’s president and CEO and join Agilent’s Board of Directors on May 1.
Feb 13, 2024 10:11 am ET
Agilent Ranked Among Top 50 Most Just Companies in America
Agilent Technologies Inc. (NYSE: A) today announced the company was again named one of the Most JUST Companies in America by Just Capital and CNBC. This marks the sixth year Agilent has appeared on the exclusive list, and the fourth year the company has ranked in the top 50.
Feb 08, 2024 08:00 am ET
Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products
Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. These accolades highlight Agilent’s commitment to innovation and excellence in drug discovery and development.
Feb 07, 2024 11:20 am ET
Agilent to Participate in TD Cowen Health Care Conference
Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston, Massachusetts, on Monday, March 4, at 2:50 p.m. EST.
Jan 30, 2024 08:00 am ET
Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology
Agilent Technologies Inc. (NYSE: A) today announced an agreement with Incyte that will bring together Agilent’s ex
Jan 25, 2024 12:29 pm ET
Agilent to Announce First-Quarter Fiscal Year 2024 Financial Results Feb. 27
Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2024 after the stock market closes on Tuesday, Feb. 27. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST.
Jan 16, 2024 08:00 am ET
Agilent Announces New ProteoAnalyzer System
Agilent Technologies Inc. (NYSE: A) today announced the release of a new automated parallel capillary electrophoresis system for protein analysis – the
Jan 05, 2024 10:29 am ET
Agilent Named to Dow Jones Sustainability Indices for Ninth Consecutive Year
Agilent Technologies Inc. (NYSE: A) today announced the company has again been included in the Dow Jones Sustainability World Index and the North America Index for its strong environmental, social, and governance (ESG) performance.
Dec 20, 2023 08:58 am ET
Agilent Makes Strategic Updates to Organizational Structure
Agilent Technologies Inc. (NYSE: A) today announced it has moved the company’s Cell Analysis Division into its Diagnostics and Genomics Group (DGG) as part of a strategy to further strengthen growth opportunities for both organizations.
Dec 18, 2023 10:01 am ET
Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 9, 2024, at 9:45 a.m. Pacific Time.
Dec 14, 2023 03:17 pm ET
Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations
Agilent Technologies Inc. (NYSE: A) today announced the company’s manufacturing facility in Waldbronn, Germany, has been named a Global Lighthouse by the World Economic Forum (WEF) for innovations that boost productivity, output, and quality.
Dec 07, 2023 08:00 am ET
Agilent Resolve Raman Receives Multiple Recognitions for HazMat and CBRN Excellence
Agilent Technologies Inc. (NYSE: A) today announced that the Agilent
Dec 04, 2023 08:00 am ET
Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology
Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the
Nov 20, 2023 04:05 pm ET
Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.69 billion for the fourth quarter ended Oct. 31, 2023, a decline of 8.7% reported and 9.7% core(1) compared to the fourth quarter of 2022.
Nov 17, 2023 11:59 am ET
Agilent to Present at the Evercore ISI HealthCONx Conference
Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, president and chief executive officer, and Bob McMahon, chief financial officer, will present at the 6th Annual Evercore ISI HealthCONx conference on Wednesday, Nov. 29, at 10:50 a.m. ET.
Nov 15, 2023 04:02 pm ET
Agilent Increases Cash Dividend to 23.6 Cents per Share
Agilent Technologies Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 23.6 cents per share of common stock, a 5% increase over the previous dividend. The quarterly dividend will be paid on Jan. 24, 2024, to all shareholders of record as of the close of business on Jan. 2, 2024.
Nov 14, 2023 08:00 am ET
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Agilent Technologies Inc. (NYSE: A) today announced that it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as a diagnostic tool to aid in identifying patients with Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma who may be eligible for treatment with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy.
Nov 13, 2023 08:00 am ET
Agilent Announces Thought Leader Award to Professor Jennifer Field
Agilent Technologies Inc. (NYSE: A) today announced that Jennifer Field, an influential researcher in environmental analysis, has been selected to receive a prestigious Agilent Thought Leader Award. A professor in the Environmental and Molecular Toxicology Department at
Oct 23, 2023 10:28 am ET
Agilent to Announce Fourth-Quarter Fiscal Year 2023 Financial Results Nov. 20
Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2023 after the stock market closes on Monday, Nov. 20. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST.
Oct 19, 2023 09:15 am ET
Agilent’s Net-Zero Emissions Targets Approved by the Science Based Targets Initiative
Agilent Technologies Inc. (NYSE: A) today announced the company’s near and long-term targets for reaching net-zero greenhouse gas emissions have been approved by the Science Based Targets initiative (SBTi). The targets support the ambitious goal to limit planetary warming to 1.5°C above pre-industrial levels.
Sep 20, 2023 03:06 pm ET
Agilent Announces Cash Dividend of 22.5 Cents Per Share
Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on Oct. 25, 2023, to all shareholders of record as of the close of business on Oct. 3, 2023.
Sep 12, 2023 08:35 am ET
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences. Financial terms of the agreement were not disclosed and are not material to either party.
Sep 05, 2023 07:20 am ET
Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group
Agilent Technologies, Inc. (NYSE: A) today announced Philip Binns has been named president of the company’s Life Sciences and Applied Markets Group (LSAG). Binns previously served as vice president and general manager of the Spectroscopy and Vacuum Solutions Division for LSAG. Binns replaces Jacob Thaysen who left the company effective today.
Aug 24, 2023 08:00 am ET
Agilent Receives European IVDR Certification for Companion Diagnostic Assay
Agilent Technologies Inc. (NYSE: A) today announced the issuing of a companion diagnostic (CDx) Class C IVDR certification for PD-L1 IHC 22C3 pharmDx, Code SK006. This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (
Aug 15, 2023 04:05 pm ET
Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the third quarter ended July 31, 2023, a decrease of 2.7% compared to the third quarter of 2022 and a decrease of 2.3% on a core(1) basis.
Aug 09, 2023 08:00 am ET
Agilent 2023 Early Career Professor Award Presented to Ajit Divakaruni
Agilent Technologies Inc. (NYSE: A) announced today that
Aug 03, 2023 08:00 am ET
Agilent Announces Thought Leader Award to Peter Neubauer
Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award. As Chair of Bioprocess Engineering at the
Jul 31, 2023 09:00 am ET
Agilent’s 2022 ESG Report Shows Progress Helping Customers Reach Their Sustainability Goals
Agilent Technologies Inc. (NYSE: A) today released its 2022 ESG report on the company’s work supporting customers with their sustainability initiatives while advancing its own internal high-priority ESG programs, from reducing Scope 3 emissions in the value chain to cultivating a talented, diverse, and inclusive workforce.
Jul 19, 2023 12:00 pm ET
Agilent to Announce Third-Quarter Fiscal Year 2023 Financial Results Aug. 15
Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2023 after the stock market closes on Tuesday, Aug. 15. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT.
Jul 10, 2023 10:52 am ET
Agilent Achieves Great Place to Work® Certification
Agilent Technologies Inc. (NYSE: A) today announced the company has achieved certification as a Great Place to Work®. The recognition reflects Agilent's commitment to creating a positive work environment that fosters employee engagement, innovation, teamwork and professional growth.
Jul 10, 2023 08:01 am ET
Agilent Announces Gen6 Software for BioTek Line of Microplate Readers
Agilent Technologies Inc. (NYSE: A) today announced the launch of new Gen6 software for all Agilent BioTek detection instruments. Featuring a broad range of prebuilt experiment templates for common applications, the new software provides automated optimization tools and improved navigation through built-in data analysis functions.
Jul 03, 2023 08:00 am ET
Agilent Innovation Again Recognized with Multiple Scientists' Choice Awards
Agilent Technologies Inc. (NYSE: A) has announced the receipt of three 2023 Scientists’ Choice Awards; Best New Spectroscopy Product of 2022, Analytical Science Video of the Year, Analytical Science Customer Service of the Year, and a Platinum Seal of Quality for their entire analytical HPLC systems. Announced on June 6th, 2023, at ASMS, these S
Jun 12, 2023 08:00 am ET
Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference
Agilent Technologies Inc. (NYSE: A) today announced they will showcase their significantly expanded InfinityLab GPC/SEC Solution at the
Jun 08, 2023 08:00 am ET
Agilent Announces BioTek 406 FX Washer Dispenser for Technology-Driven Workflow Efficiency
Agilent Technologies Inc. (NYSE: A) today announced the release of the
Jun 08, 2023 08:00 am ET
Agilent Independent Global Lab Sustainability Survey Sheds Light on Progress Towards Greener Labs
Agilent Technologies Inc. (NYSE: A) today announced the results of an independent third-party global survey that will help the industry better understand analytical laboratories’ perceptions, aspirations, and challenges concerning implementing sustainability measures.
Jun 06, 2023 08:00 am ET
Agilent Announces Enhanced xCELLigence RTCA Software Pro to Support Regulatory Compliance Requirements
Agilent Technologies Inc. (NYSE: A) today announced the release of the enhanced
Jun 05, 2023 08:00 am ET
Agilent Announces Full Workflow for US EPA Method 1633 for Targeted PFAS Analysis
Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated, complete workflow solution for targeted per- and polyfluoroalkyl substances (PFAS) analysis using the United States (US) Environmental Protection Agency (EPA)
Jun 05, 2023 08:00 am ET
Agilent Announces Inspirational LC/TQ and LC/Q-TOF Mass Spectrometry Solutions at ASMS 2023
Agilent Technologies Inc. (NYSE: A) today announced two new liquid chromatography mass spectrometry systems (LCMS), the Agilent 6495D LC/TQ and the Agilent Revident LC/Q-TOF. Facilitating the high-end performance of the Revident LC/Q-TOF, Agilent is also announcing the new Agilent MassHunter Explorer Profiling software and the ne
Jun 02, 2023 08:00 am ET
Agilent Intelligent Mass Spectrometry Solutions to Inspire at ASMS 2023
Agilent Technologies Inc. (NYSE: A) today announced new mass spectrometry solutions on show at the
May 23, 2023 04:05 pm ET
Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.72 billion for the second quarter ended April 30, 2023, an increase of 6.8% compared to the second quarter of 2022 and up 9.5% on a core(1) basis.
May 22, 2023 06:00 pm ET
Agilent to Present at Jefferies and Goldman Sachs Healthcare Conferences
Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in Q&A sessions at the Jefferies and Goldman Sachs healthcare conferences. Below are details of each session.
May 18, 2023 09:25 pm ET
Agilent to Appeal Patent Office Decision on CRISPR gRNA Patents
Agilent Technologies Inc. (NYSE: A), announced today the company intends to appeal the U.S. Patent and Trademarks Office (USPTO) Patent Trial and Appeal Board’s (PTAB) Final Written Decision in connection with the Inter Partes review (IPR) of U.S. Patent Nos. 10,337,001 & 10,900,034 (the Agilent Patents). The PTAB recently reversed the USPTO’s original decision granting claims directed towards chemically modified synthetic CRISPR guide RNA.
May 17, 2023 03:57 pm ET
Agilent Announces Cash Dividend of 22.5 Cents Per Share
Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on July 26, 2023, to all shareholders of record as of the close of business on July 3, 2023.
May 16, 2023 02:47 pm ET
Agilent Wins SEAL Award for Innovative Products that Help Customers Achieve Their Sustainability Goals
Agilent Technologies Inc. (NYSE: A) today received a SEAL Business Sustainability Award for producing products and technology that are helping analytical and clinical labs reduce their carbon footprint.
May 04, 2023 08:00 am ET
Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye
Agilent Technologies Inc. (NYSE: A) announced today that Dr. Jiangbin Ye
Apr 26, 2023 01:05 pm ET
Agilent to Announce Second-Quarter Fiscal Year 2023 Financial Results May 23
Agilent Technologies Inc. (NYSE: A) will release financial results and hold an earnings conference call for the second quarter of fiscal year 2023 after the stock market closes on Tuesday, May 23 at 1:30 p.m. PDT.
Apr 14, 2023 08:00 am ET
Agilent Showcases Comprehensive Cancer Portfolio Solutions at AACR 2023
Agilent Technologies Inc. (NYSE: A) announced today that it will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions at the
Apr 13, 2023 08:29 am ET
Agilent Announces NGS Assay for Comprehensive Genomic Profiling (CGP) for Advancing Precision Oncology
Agilent Technologies Inc. (NYSE: A) today announced the launch of the
Apr 12, 2023 08:00 am ET
Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications
Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI, a leading provider of
Apr 03, 2023 08:00 am ET
Agilent Announces High-Performance Cary 3500 Flexible UV-Vis System
Agilent Technologies Inc. (NYSE: A) today announced the latest addition to the Cary 3500 UV-Vis Series with the release of the
Apr 03, 2023 03:00 am ET
Agilent Announces Thought Leader Award to Dr. Chenli Liu
Agilent Technologies Inc. (NYSE: A) today announced that
Mar 23, 2023 08:00 pm ET
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research Institute Scientist, Kathryn Wolhuter
Agilent Technologies Inc. (NYSE: A) announced today that the recipient of the
Mar 20, 2023 02:00 pm ET
Agilent Announced as Instrument Business Outlook 2022 Company of the Year
Agilent Technologies Inc. (NYSE: A) announced today that it has been selected as
Mar 10, 2023 08:01 am ET
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated end-to-end solution for digital pathology that brings together best-in-class products from
Mar 10, 2023 08:00 am ET
Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu
Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamat
Mar 09, 2023 04:05 pm ET
Agilent Again Named One of Barron’s 100 Most Sustainable Companies
For the sixth consecutive year, Agilent Technologies (NYSE: A) is ranked among the top 20 in Barron’s list of America’s 100 Most Sustainable Companies.
Mar 09, 2023 02:10 pm ET
Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development
Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell.
Mar 08, 2023 08:00 am ET
Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine
Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia® – a leader
Mar 06, 2023 01:30 pm ET
Agilent to Present at Barclays Global Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Bob McMahon will participate in a Q&A session at the Barclays Global Healthcare Conference in Miami Beach, Florida, on March 15 at 3:05 p.m. EST.
Feb 28, 2023 04:05 pm ET
Agilent Reports First-Quarter Fiscal Year 2023 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.76 billion for the first quarter ended January 31, 2023, an increase of 5% compared to the first quarter of 2022 and up 10% on a core(1) basis.
Feb 27, 2023 08:00 am ET
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler
Agilent Technologies Inc. (NYSE: A) today announced the release of an
Feb 24, 2023 08:00 am ET
Feb 22, 2023 04:10 pm ET
Agilent Announces Cash Dividend of 22.5 Cents Per Share
Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 22.5 cents per share of common stock will be paid on April 26, 2023, to all shareholders of record as of the close of business on April 4, 2023.
Feb 22, 2023 08:00 am ET
Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions
Agilent Technologies Inc. (NYSE: A) announced today that it will highlight a suite of automated laboratory workflow solutions at the
Feb 16, 2023 05:43 pm ET
Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick
Leaders from Agilent Technologies Inc. (NYSE: A) today joined Colorado Governor Jared Polis and local government officials to break ground on Agilent’s $725 million investment to double manufacturing capacity of therapeutic nucleic acids in Frederick, Colorado.
Feb 09, 2023 08:00 am ET
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
Agilent Technologies Inc. (NYSE: A) today announced the release of new
Jan 30, 2023 01:29 pm ET
Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28
Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2023 after the stock market closes on Tuesday, Feb. 28. The company will host a live webcast of its earnings conference call in listen-only mode on the same day. Below are details for the webcast:
Jan 23, 2023 08:00 am ET
Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test
Agilent Technologies Inc. (NYSE: A) today announced an agreement with Quest Diagnostics
Jan 18, 2023 01:23 pm ET
Agilent Included in Just Capital’s 2023 List of Most Just Companies
Agilent Technologies Inc. (NYSE: A) is ranked 35 among the top 100 Most JUST companies, the fifth year the company has been included in the annual list by Just Capital and CNBC. Agilent also earned the top ranking in its sector for industry-leading performance regarding treatment of employees, customers
Jan 09, 2023 04:30 pm ET
Agilent Authorizes $2 Billion Share Repurchase Program
Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has approved a new share repurchase program. The 2023 program authorizes the purchase of up to $2 billion of the company’s common stock.
Jan 09, 2023 08:45 am ET
Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).
Jan 06, 2023 08:00 am ET
Jan 04, 2023 08:45 am ET
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
Agilent Technologies Inc. (NYSE: A) today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS) approaches to study cancer.
Dec 16, 2022 01:30 pm ET
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the Goldman Sachs Healthcare CEOs Unscripted Conference and the J.P. Morgan Healthcare Conference. Both conference presentations will be webcast live. Details are included below.
Dec 12, 2022 08:50 pm ET
Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer
Agilent Technologies Inc. (NYSE: A) announced today that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatment with
Dec 07, 2022 01:44 pm ET
Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies
Agilent Technologies Inc. (NYSE: A) today announced the company is ranked 101 in Newsweek’s 2023 list of America’s Most Responsible Companies, up 28 places from 2022. It marks Agilent’s fourth consecutive year on the prestigious lis
Dec 05, 2022 08:00 am ET
Agilent Opens Customer Experience Center Highlighting Genomics and Diagnostics Solutions
Agilent Technologies Inc. (NYSE: A) today announced the opening of a new Customer Experience Center (CEC) in Lexington, MA, focused on solutions from Agilent genomics and diagnostics product portfolios. The facility will serve as a regional hub for Agilent representatives to showcase and demonstrate both product capabilities and complete workflow
Nov 30, 2022 08:00 am ET
Agilent Attains ‘Angel’ Level Sponsorship with My Green Lab
Agilent Technologies Inc. (NYSE: A) today announced that it has become the first ‘Angel’ level sponsor of My Green Lab, a nonprofit organization dedicated to building a global culture of sustainability in science.
Nov 29, 2022 08:00 am ET
Agilent Deploys Next Generation Explosive Detection System at London Heathrow Airport
Agilent Technologies Inc. (NYSE: A) today announced the deployment of the next generation of alarm resolution technology for checkpoints throughout London Heathrow airport, delivering advanced security and efficiency. The Insight200M from Agilent ensures increased safety on planes while improving passenger experience at airports.
Nov 22, 2022 08:31 am ET
Thinking about trading options or stock in Burlington Stores, BP, Agilent Technologies, Sony, or Amazon?
NEW YORK, Nov. 22, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BURL, BP, A, SONY, and AMZN.
Nov 21, 2022 04:05 pm ET
Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.85 billion for the fourth quarter ended Oct. 31, 2022, an increase of 11% compared to the fourth quarter of 2021 and up 17% on a core(1) basis. Revenue for the full year was $6.85 billion, delivering 8% reported growth and core(1) growth of 12%.
Nov 16, 2022 04:05 pm ET
Agilent Announces Cash Dividend of 22.5 Cents Per Share
Agilent Technologies Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 22.5 cents per share of common stock, reflecting a 7% increase over the previous quarter. The quarterly dividend will be paid on January 25, 2023, to all shareholders of record as of the close of business on January 3, 2023.
Nov 15, 2022 07:00 pm ET
Agilent to Present at the Evercore ISI HealthCONx Conference
Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, president and chief executive officer, and Bob McMahon, chief financial officer, will present at the 5th Annual Evercore ISI HealthCONx conference on Wednesday, November 30, at 10:50 a.m. PST.
Nov 14, 2022 08:00 am ET
Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0
Agilent Technologies Inc. (NYSE: A) today announced the release of the AssayMAP Bravo Protein Sample Prep Workbench 4.0 software. This release adds 21 CFR Part 11 compliance-enabling features that allow AssayMAP Bravo-based automated sample preparation in workflows across the biopharma drug development process.
Nov 07, 2022 08:00 am ET
Agilent Joins the How2Recycle Program
Agilent Technologies Inc. (NYSE: A) has become a member of How2Recycle®, a standardized labeling system owned by Delaware nonprofit Green Blue Institute, Inc. The program involves a coalition of forward-thinking brands who want their packaging to be recycled and are empowering consumers to do it through smart packaging labels.
Nov 01, 2022 02:30 pm ET
Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21
Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the fourth quarter of fiscal year 2022 after the stock market closes on Monday, Nov. 21. The company will host a live webcast of its investor conference call in listen-only mode on the same day.
Oct 12, 2022 08:00 am ET
Agilent Opens Center of Excellence for Dissolution Products
Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, quality, support, applications, marketing, and more. This investment allows
Oct 11, 2022 02:00 am ET
World Economic Forum Recognizes Agilent Facility in Singapore as a Leader in Advanced Manufacturing
Agilent Technologies Inc. (NYSE: A) today announced the World Economic Forum’s Global Lighthouse Network has named Agilent’s facility in Singapore a Fourth Industrial Revolution (4IR) leader for effectively deploying innovative technologies at scale in the manufacture of scientific instruments.
Oct 03, 2022 08:00 am ET
Agilent Announces Enhanced 8700 LDIR Chemical Imaging System for Microplastics Analysis
Agilent Technologies Inc. (NYSE: A) today announced the release of its enhanced
Sep 29, 2022 01:01 pm ET
Agilent Launches Partnership with Delaware State University to Advance Diversity in Science, Technology, Engineering and Math (STEM) Fields
Agilent Technologies Inc. (NYSE: A) is launching a partnership with Delaware State University (DSU), a leading historically Black university, to increase the share of underrepresented students entering STEM fields, a central mission of the company’s philanthropic work through the Agilent Foundation.
Sep 21, 2022 04:05 pm ET
Agilent Announces Cash Dividend of 21 Cents Per Share
Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on October 26, 2022, to all shareholders of record as of the close of business on October 4, 2022.
Sep 14, 2022 01:48 pm ET
Agilent Earns Great Place to Work® Certification in 20 Countries and Regions
Agilent Technologies Inc. (NYSE: A) today announced the company has achieved Great Place to Work® Certification™ in 20 countries and regions, a recognition that distinguishes Agilent as a top employer based on an independent survey of its global workforce.
Sep 12, 2022 08:00 am ET
Agilent Announces Thought Leader Award to Professor Christoph Herwig
Agilent Technologies Inc. (NYSE: A) today announced
Sep 08, 2022 12:32 pm ET
Fortune Ranks Agilent Among Top Workplaces in Health Care
Agilent Technologies Inc. (NYSE: A) today announced that the company has been named a “Best Workplace in Health Care” in the United States by Fortune magazine. Agilent’s number 17 ranking is based on the Great Place to Work® employee survey and company-provided data.
Sep 07, 2022 03:25 pm ET
Agilent Receives Award for Sustainability Leadership
Agilent Technologies Inc. (NYSE: A) has received an award for leadership in advancing environmental sustainability from the Business Intelligence Group. The award recognizes Agilent’s sustainability efforts across all its operations and through all its products and services, which are used in more than 265,000 labs worldwide.
Sep 01, 2022 08:00 am ET
Agilent Collaborates with METTLER TOLEDO to Reduce Errors in Sample Preparation Workflows for Better Chromatographic Results
Agilent Technologies Inc. (NYSE: A) today announced that it is collaborating with METTLER TOLEDO to address one of the biggest concerns in any laboratory—error-prone sample preparation. This integrated solution allows the automatic and seamless transfer of weighing results and the associated metadata from METTLER TOLEDO LabX™ Balance software to
Aug 17, 2022 09:33 am ET
Thinking about trading options or stock in Tesla, Agilent Technologies, Dollar Tree, Walmart, or Alibaba?
NEW YORK, Aug. 17, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TSLA, A, DLTR, WMT, and BABA.
Aug 16, 2022 04:05 pm ET
Agilent Reports Third-Quarter Fiscal Year 2022 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.72 billion for the third quarter ended July 31, 2022, an increase of 8% compared to the third quarter of 2021 and up 13% on a core(1) basis.
Aug 02, 2022 08:30 am ET
Agilent Acquires Polymer Standards Service, Broadening Offerings for GPC/SEC Polymer Analysis
Agilent Technologies Inc. (NYSE: A) today announced it has acquired Polymer Standards Service GmbH (PSS), a provider of solutions in the field of polymer characterization. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solutions for g
Aug 02, 2022 08:07 am ET
Jul 27, 2022 08:06 am ET
Agilent 2022 Early Career Professor Award Presented to Stefanos Nikolaidis
Agilent Technologies Inc. (NYSE: A) announced today that
Jul 25, 2022 09:00 am ET
Agilent ESG Report Highlights Plans and Progress to Ensure Future Sustainable Growth
Agilent Technologies Inc. (NYSE: A) today released its inaugural Environmental, Social, and Governance (ESG) report, including the company’s first TCFD climate risk report; details on its commitment to reach net-zero greenhouse gas emissions by 2050; and progress on cultivating a diverse, i
Jul 19, 2022 01:09 pm ET
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award
Agilent Technologies Inc. (NYSE: A) today announced the company’s Certified Pre-Owned Instruments Program received a Top Project award for achieving outstanding results in reducing waste. The award is sponsored by
Jul 19, 2022 11:00 am ET
Agilent to Announce Third-Quarter Fiscal Year 2022 Financial Results August 16
Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16. The company will host a live webcast of its investor conference call in listen-only mode on the same day.
Jul 11, 2022 08:10 am ET
Halo Labs Completes $6M Series C Growth Financing
BURLINGAME, Calif., July 11, 2022 /PRNewswire/ -- Halo Labs, a leading life science instrumentation company announced it has raised $6M in series C financing. The round was led by Agilent Technologies Inc. and includes participation from existing investors Research Corporation Technologies, Broad Oak Capital Partners, BioAdvance, and members of the Board of Directors and senior management.
Jul 05, 2022 08:00 am ET
Teva Uses the Agilent TRS100 to Achieve Regulatory Milestone for Content Uniformity Testing with the FDA
Agilent Technologies Inc. (NYSE: A) announced today that the FDA has approved a content uniformity (CU) method using the Agilent TRS100 Raman quantitative pharmaceutical analysis system.
Jun 21, 2022 08:00 am ET
Agilent Laboratory Achieves Green Lab Certification
Agilent Technologies Inc. (NYSE: A) today announced that the company’s customer demonstration laboratory in Waldbronn, Germany has received the highest level of
Jun 16, 2022 08:00 am ET
Agilent Showcases ‘Consistent, Greener, Smarter’ Approach at Analytica 2022
Agilent Technologies Inc. (NYSE: A) today announced that it will showcase its latest workflows and solutions at Analytica 2022, being held 21 to 24 June 2022 in Munich, Germany.
Jun 15, 2022 08:00 am ET
Agilent Wins Multiple 2022 Scientists' Choice Awards at ASMS
Agilent Technologies Inc. (NYSE: A) announced that it has received three 2022 Scientists’ Choice Awards including Best New Spectroscopy Product of 2021. Announced at the
Jun 07, 2022 10:35 am ET
Agilent Leverages NVIDIA and AWS Technology to Improve Analysis Speeds of Genomics Bioinformatics Pipelines
Agilent Technologies Inc. (NYSE: A), a global leader in genomics technology, today announced it will use Amazon Elastic Compute Cloud (Amazon EC2) G5g instances powered by Amazon Web Services (AWS) Graviton2 processors and featuring NVIDIA T4G Tensor Core GPUs, in combination with
Jun 06, 2022 08:00 am ET
Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research
Agilent Technologies Inc. (NYSE: A) today announced the release of its
Jun 06, 2022 08:00 am ET
Agilent Announces New Revolutionary Quadrupole Mass Spectrometers at ASMS 2022
Agilent Technologies Inc. (NYSE: A) today announced new LC/MS and GC/MS quadrupole mass spectrometers which will be on show at the
Jun 01, 2022 04:30 pm ET
Agilent to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Goldman Sachs 43rd Annual Healthcare Conference on Wednesday, June 15, in Rancho Palos Verdes, California.
Jun 01, 2022 08:00 am ET
Agilent Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union
Agilent Technologies Inc. (NYSE: A) today announced that previously CE-IVD marked instruments, kits, and reagents were released as IVDR Class A on May 26, 2022, in compliance with the new EU IVDR regulation.
May 27, 2022 08:00 am ET
Agilent Announces Collaboration with APC on Real-Time Process Monitoring
Agilent Technologies Inc. (NYSE: A) today announced a collaboration agreement with APC Ltd., in which the com
May 24, 2022 04:05 pm ET
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.61 billion for the second quarter ended April 30, 2022, an increase of 5% compared to the second quarter of 2021 and up 7% on a core(1) basis.
May 18, 2022 04:05 pm ET
Agilent Announces Cash Dividend of 21 Cents per Share
Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on July 27, 2022, to all shareholders of record as of the close of business on July 5, 2022.
May 10, 2022 03:50 pm ET
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in identifying cervical cancer patients for whom treatment with KEYTRUDA® (pembrolizumab) may be appropriate.1 KEYTRUDA is an anti-PD-1 therap
Apr 26, 2022 11:00 am ET
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
Agilent Technologies Inc. (NYSE: A) today announced that it will release financial results for the second quarter of fiscal year 2022 after the stock market closes on Tuesday, May 24. The company will host a live webcast of its investor conference call in listen-only mode on the same day.
Apr 19, 2022 08:00 am ET
Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
Agilent Technologies Inc. (NYSE: A) announced that it has joined the
Apr 08, 2022 08:00 am ET
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the
Apr 05, 2022 08:25 am ET
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
Agilent Technologies Inc. (NYSE: A) today announced CE-IVD marking in the European Union for its PD-L1 IHC 28-8 pharmDx immunohistochemical assay to extend the use of the test to patients diagnosed with muscle-invasive urothelial carcinoma (MIUC) who have tumor cell PD-L1 expression ≥ 1% for adjuvant treatment with OPDIVO® (nivolumab), a PD-1-ta
Apr 05, 2022 08:15 am ET
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
Agilent Technologies Inc. (NYSE: A) today announced it has expanded CE-IVD marking in the European Union for its PD-L1 IHC 28-8 pharmDx as an aid in identifying esophageal squamous cell carcinoma patients for treatment with Bristol Myers Squibb’s PD-1-targeted immunotherapeutic
Apr 04, 2022 08:00 am ET
Agilent Joins AMBIC to Advance Biomanufacturing
Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the
Mar 10, 2022 08:00 am ET
Feb 24, 2022 01:52 pm ET
Agilent to Participate at Cowen and Barclays Health Care Conferences
Agilent Technologies Inc. (NYSE: A) today announced that Bob McMahon, senior vice president and chief financial officer, will participate in Q&A sessions at the Cowen 42nd Annual Health Care Conference and the Barclays Global Health Care Conference. Below are the details:
Feb 24, 2022 08:00 am ET
Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
Agilent Technologies Inc. (NYSE: A) and the University of Vermont (UVM) today announced the establ
Feb 23, 2022 08:00 am ET
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
Agilent Technologies Inc. (NYSE: A) announced today that researchers from the
Feb 22, 2022 04:05 pm ET
Agilent Reports First-Quarter Fiscal Year 2022 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the first quarter ended Jan. 31, 2022, an increase of 8% compared to the first quarter of 2021 and up 9% on a core(1) basis.
Feb 17, 2022 09:00 am ET
Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity
Agilent Technologies Inc. (NYSE: A) today announced it has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine learning software developer that creates innovative analysis solutions in lab testing. Agilent will integrate the software, known as ACIES, into its industry-leading gas chromatography and mass spectrometry (GS/MS) platforms to improve the productivity, efficiency and accuracy of high-throughput labs the company serves around the world.
Feb 15, 2022 04:05 pm ET
Agilent Announces Cash Dividend of 21 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on April 27, 2022, to all shareholders of record as of the close of business on April 5, 2022.
Feb 04, 2022 08:00 am ET
Agilent Highlights Integrated Automation Solutions at SLAS 2022
Agilent Technologies Inc. (NYSE: A) highlights innovative laboratory automation solutions at the
Jan 26, 2022 08:00 pm ET
Agilent and A*STAR’s SIFBI Sign Research Collaboration Agreement to Advance Singapore Agri-Food Industry
Agilent Technologies Inc. (NYSE: A) recently signed a Research Collaboration Agreement (RCA) with the
Jan 24, 2022 08:30 am ET
Agilent Announces the Innovative Seahorse XF Pro Analyzer
Agilent Technologies Inc. (NYSE: A) today announced the release of the
Jan 13, 2022 04:05 pm ET
Agilent to Webcast First-Quarter Fiscal Year 2022 Financial Results Presentation
Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal year 2022 financial results after the stock market closes on Tuesday, Feb. 22. The company will host a live webcast of its investor conference call in listen-only mode on the same day.
Jan 10, 2022 08:18 am ET
Agilent Presents Thought Leader Award to Professor Jason Kovacic
Agilent Technologies Inc. (NYSE: A) today announced that
Dec 14, 2021 11:00 am ET
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual Healthcare Conference. Both conferences will be webcast. Details are included below.
Dec 06, 2021 08:00 am ET
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
Agilent Technologies Inc. (NYSE: A) has announced that the
Nov 23, 2021 03:00 pm ET
Agilent to Present at Evercore ISI Virtual Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced the company’s presentation at the Evercore ISI Virtual Healthcare Conference will be made available by webcast. The details:
Nov 22, 2021 04:05 pm ET
Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.66 billion for the fourth quarter ended Oct. 31, 2021, up 12% year over year (core(1) growth of 11%). Revenue for the full year was $6.32 billion, delivering 18% reported growth (core(1) growth of 15%), up a record $980 million above that of fiscal year 2020.
Nov 18, 2021 04:05 pm ET
Dr. Otis Brawley Named to Agilent Board of Directors
Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Otis W. Brawley, a Bloomberg Distinguished Professor with the Department of Oncology and Epidemiology at the Johns Hopkins University School of Medicine, has been elected to Agilent’s board of directors, effective Nov. 17, 2021.
Nov 17, 2021 04:05 pm ET
Agilent Increases Cash Dividend to 21 Cents Per Share
Agilent Technologies, Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 21 cents per share of common stock, reflecting an 8% increase over the previous quarter. The quarterly dividend will be paid on Jan. 26, 2022 to all shareholders of record as of the close of business on Jan. 4, 2022.
Nov 02, 2021 02:00 pm ET
Agilent Names John Palma to Lead Global Medical Affairs Organization
Agilent Technologies, Inc. (NYSE: A) today announced that John Palma has joined the company as vice president, Medical Affairs. In this role, he will build and lead the companywide Global Medical Affairs organization.
Nov 01, 2021 08:06 am ET
Oct 28, 2021 04:47 pm ET
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labelled for use in TNBC in the European Union.
Oct 28, 2021 04:05 pm ET
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
Agilent Technologies Inc. (NYSE: A) will release fourth-quarter fiscal year 2021 financial results after the stock market closes on Monday, November 22. The company will host a live webcast of its investor conference call in listen-only mode on the same day.
Oct 27, 2021 08:00 am ET
Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
Agilent Technologies, Inc. (NYSE: A) today announced its commitment to achieve net-zero greenhouse gas emissions no later than 2050. The commitment adds to the global effort by governments, corporations, and other institutions to limit warming of the climate to 1.5°C above pre-industrial levels, a goal of the 2015 Paris Agreement on climate change.
Oct 26, 2021 08:05 am ET
Agilent Announced as My Green Lab's First 'Transformative Level' Sponsor and First Sponsor of the My Green Lab Certification Program
SANTA CLARA, Calif., Oct. 26, 2021 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) announced today that it has undertaken the highest sponsorship level of My Green Lab—Transformative Level—as the first institution to do so. Since 2019, Agilent has proudly partnered with My Green Lab, the world's leading nonprofit organization dedicated to improving the sustainability of scientific research.
Oct 21, 2021 08:31 am ET
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Agilent Technologies Inc. (NYSE: A) today announced it has received CE-IVD mark approval for the PD-L1 IHC 28-8 pharmDx to guide options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers.
Oct 13, 2021 04:16 pm ET
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered. This is the first
Sep 28, 2021 08:00 am ET
Sep 23, 2021 04:05 pm ET
Dr. Mikael Dolsten Named to Agilent Board of Directors
Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to Agilent’s board of directors, effective Sept. 21, 2021.
Sep 22, 2021 04:05 pm ET
Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on Oct. 27, 2021, to all shareholders of record as of the close of business on Oct. 5, 2021.
Sep 07, 2021 08:00 am ET
Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute
Agilent Technologies Inc. (NYSE: A) today announced Dr. David R. Liu has bee
Sep 02, 2021 08:00 am ET
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
Agilent Technologies Inc. (NYSE: A) today announced the signing of a worldwide distribution agreement with Visiop
Sep 01, 2021 11:00 am ET
Agilent to Present at Wells Fargo Virtual Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, Agilent President and CEO, and Bob McMahon, Agilent CFO, will participate in a “fireside chat” discussion at the Wells Fargo Virtual Healthcare Conference Sept. 9. The presentation will be webcast live.
Aug 23, 2021 11:00 am ET
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer
Agilent Technologies Inc. (NYSE: A) today announced that the company’s PD-L1 IHC 22C3 pharmDx assay has expanded its use in Europe. The assay is now CE-IVD marked for use as an aid in identifying esophageal cancer patients for treatment with KEYTRUDA using Combined Positive Score (CPS) ≥ 10.1 In Europe, KEYTRUDA is approved in combina
Aug 19, 2021 08:00 am ET
Researchers Develop COVID-19 Severity Screening Method Based on the Agilent Cary 630 FTIR Spectrometer
Agilent Technologies Inc. (NYSE: A) announces that researchers at the Indian Instit
Aug 17, 2021 04:05 pm ET
Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.59 billion for the third quarter ended July 31, 2021, an increase of 26% compared to the third quarter of 2020 and up 21% on a core(1) basis.
Aug 04, 2021 11:00 am ET
Agilent Earns 2021 Great Place to Work Certification in the U.S.
Agilent Technologies Inc. (NYSE: A) today announced that it has been certified as a Great Place to Work in the U.S., a prestigious independent recognition based entirely on employee feedback about leadership behavior, integrity, camaraderie, and 17 other dimensions of corporate excellence.
Aug 03, 2021 08:20 am ET
Agilent Announces Target Enrichment Manufacturing Facility in China
Agilent Technologies Inc. (NYSE: A) today announced that is has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China.
Jul 28, 2021 08:00 am ET
Agilent Early Career Professor Award Presented to Jason H. Yang
Agilent Technologies Inc. (NYSE: A) today announced that Jason H. Yang, Ph.D.
Jul 27, 2021 08:00 am ET
Clinical Utility of ALK Fusion Detection by Liquid Biopsy
Agilent Technologies Inc. (NYSE: A) today announced the publication of a paper in the journal Lung Cancer, titled "Clinical Utility of Next-Generation Sequencing-Based ctDNA Testing for Common and Novel ALK Fusions". The study, jointly published by Resolution Bioscience (now a part of Agilent) and Memorial Sloan Kettering Ca
Jul 22, 2021 11:00 am ET
Agilent Technologies Celebrates More than 20 Years of Sustainable Progress
Agilent Technologies, Inc. (NYSE: A) today issued its 21st annual Corporate Social Responsibility (CSR) report. The report highlights the company’s progress in critical environmental, social and governance (ESG) areas as well its commitment to employees, customers, part
Jul 21, 2021 08:00 am ET
Agilent to Webcast Third-Quarter Fiscal Year 2021 Financial Results Presentation
Agilent Technologies Inc. (NYSE: A) will release third-quarter fiscal year 2021 financial results after the stock market closes on Tuesday, August 17. The company will host a live webcast of its investor conference call in listen-only mode on the same day.
Jul 20, 2021 12:34 pm ET
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
Agilent Technologies Inc. (NYSE: A) today announced that the company’s PD-L1 IHC 22C3 pharmDx assay is now labeled for expanded use in patients with non-small cell lung cancer (NSCLC) in the European Union. PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying NSCLC patients with tumor PD-L1 expression of Tumor Proportion Score (TPS) ≥
Jul 20, 2021 08:30 am ET
Agilent Announces Optimized and Verified Method for Testing Over 100 PFAS Compounds
Agilent Technologies Inc. (NYSE: A) today announced the availability of an optimized and verified
Jul 13, 2021 09:00 am ET
MOBILion Systems Inc. Announces $60 Million Series C Financing Round Led by D1
CHADDS FORD, Pa., July 13, 2021 /PRNewswire/ -- MOBILion Systems Inc., a pioneer in fast, efficient, highresolution instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, today announced the close of a $60 million Series C financing round. The round was led by D1 Capital Partners with the remaining funds contributed by existing investors aMoon, Agilent Technologies (NYSE:A), IP Group, Hostplus and Cultivation Capital.
Jun 28, 2021 08:00 am ET
Resolution Bioscience (a part of Agilent) Investigated Acquired Resistance to KRAS G12C Inhibition
Agilent Technologies Inc. (NYSE: A) today announced the publication of a study carried out in partnership with
Jun 22, 2021 03:00 am ET
Agilent Completes the InfinityLab Bio LC Portfolio
Agilent Technologies Inc. (NYSE: A) today announced the launch of three
Jun 14, 2021 08:00 am ET
Agilent Presents Thought Leader Award to Dr. Stéphane Bayen
Agilent Technologies Inc. (NYSE: A) today announced that Stéphane Bayen
Jun 04, 2021 08:00 am ET
Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer
Agilent Technologies Inc. (NYSE: A) today announced a presentation by Memorial Sloan Kettering Cancer Center (MSK) at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) to discuss the
Jun 02, 2021 08:00 am ET
Agilent Announces New SureSelect Human All Exon V8
Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect H
Jun 01, 2021 08:00 am ET
Agilent Presents Thought Leader Award to Professor Chris Elliott
Agilent Technologies Inc. (NYSE: A) today announced that Chris Elliott has received an Agilent Thought Leader Award. Dr. Elliott is Professor of Food Safety in the School of Biological Sciences and founder of the Institute for Global Food Security (IGFS) at
May 25, 2021 04:05 pm ET
Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.525 billion for the second quarter ended April 30, 2021, an increase of 23% compared to the second quarter of 2020 and up 19% on a core(1) basis.
May 20, 2021 01:12 pm ET
Agilent to Present at Jefferies Virtual Healthcare Conference
Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Jefferies Virtual Healthcare Conference on June 1. Details are included below:
May 19, 2021 04:05 pm ET
Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on July 28, 2021, to all shareholders of record as of the close of business on July 6, 2021.
May 03, 2021 03:00 pm ET
Agilent to Webcast Second-Quarter Fiscal Year 2021 Financial Results Presentation
Agilent Technologies Inc. (NYSE: A) will release second-quarter fiscal year 2021 financial results after the stock market closes on Tuesday, May 25. The company will host a live webcast of its investor conference call in listen-only mode on the same day.
Apr 22, 2021 08:02 am ET
Agilent LC/MS Instruments Receive ACT Labels from My Green Lab
Agilent Technologies Inc. (NYSE: A) announced today that both the
Apr 20, 2021 12:19 pm ET
Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year
Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and inclusive workplace.
Apr 15, 2021 04:05 pm ET
Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology
Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions.
Apr 13, 2021 08:00 pm ET
Agilent Named One of Singapore’s Best Employers
Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a leading Singapore-based newspaper. Specifically, Agilent is ranked among the top 100 companies and fifth out of eight in the Drugs & Biotechnology category.
Mar 30, 2021 08:00 am ET
Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentral
Agilent Technologies Inc. (NYSE: A) announces that Octagon Therapeutics has been
Mar 17, 2021 04:05 pm ET
Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on April 28, 2021, to all shareholders of record as of the close of business on April 6, 2021.
Mar 15, 2021 08:00 am ET
Agilent Announces the 8697 Headspace Sampler with Integrated Intelligence
Agilent Technologies Inc. (NYSE: A) today introduced the Agi
Mar 09, 2021 12:07 pm ET
Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company’s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company’s presence in the health-care industry. As Agilent’s first CMO, she will play a key role in the company’s efforts to expand its leadership in precision medicine, supporting development of novel therapeutics to allow clinicians to identify appropriate patients and ultimately improve patient outcomes.
Mar 09, 2021 08:00 am ET
Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection
Agilent Technologies Inc. (NYSE: A) today announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. The CE-IVD mark is in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC and is available for immediate distribution.
Mar 03, 2021 05:56 pm ET
Agilent Technologies Announces Pricing of $850 Million of Senior Notes
Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $850 million. The offering is being conducted under an automatic shelf registration statement on file with the Securities and Exchange Commission. The notes will mature in March 2031 and will bear interest at an annual rate of 2.300 percent. The offering is expected to close on March 12, 2021, subject to the satisfaction of customary closing conditions.
Mar 03, 2021 08:40 am ET
Agilent Technologies Announces Proposed Offering of Senior Notes
Agilent Technologies Inc. (NYSE:A) today announced it is offering, subject to market and other conditions, a series of senior notes under an automatic shelf registration statement on file with the Securities and Exchange Commission. Actual terms of the notes, including interest rate, principal amount, and maturity, will depend on market conditions at the time of pricing.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.